Biotech · Private company

Tesaro, Inc.

Track this companyFree. Adds Tesaro, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2514 recruiting or active

Pipeline programs23From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline23

CarboplatinPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
DostarlimabPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Dostarlimab (TSR-042)Phase 3 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
NiraparibPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
NiraparibPhase 3 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 2 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 2 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
TSR-042Phase 2 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Carboplatin-PaclitaxelPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Carboplatin-PemetrexedPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
FOLFIRIPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
mFOLFOX6Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Niraparib CapsulePhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Niraparib TabletPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
TSR-022Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
TSR-033Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
TSR-042Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)PHASE2 · TERMINATED · started Apr 14, 2022ClinicalTrials.gov NCT06964165 · fetched Nov 12, 2026
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryPHASE2 · RECRUITING · started Apr 2, 2021ClinicalTrials.gov NCT04774419 · fetched Nov 12, 2026
Niraparib + Dostarlimab + RT in Pancreatic CancerPHASE2 · COMPLETED · started Jul 23, 2020ClinicalTrials.gov NCT04409002 · fetched Nov 12, 2026
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in MelanomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 12, 2020ClinicalTrials.gov NCT04139902 · fetched Nov 12, 2026
Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 26, 2020ClinicalTrials.gov NCT04068753 · fetched Nov 12, 2026
Trial of Maintenance With Niraparib- Uterine Serous CarcinomaPHASE2 · COMPLETED · started Dec 30, 2019ClinicalTrials.gov NCT04080284 · fetched Nov 12, 2026
Niraparib/TTFields in GBMPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 30, 2019ClinicalTrials.gov NCT04221503 · fetched Nov 12, 2026
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsPHASE2 · RECRUITING · started Dec 11, 2019ClinicalTrials.gov NCT04165772 · fetched Nov 12, 2026
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 15, 2019ClinicalTrials.gov NCT03955978 · fetched Nov 12, 2026
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 6, 2019ClinicalTrials.gov NCT03368729 · fetched Nov 12, 2026
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 18, 2019ClinicalTrials.gov NCT03981796 · fetched Nov 12, 2026
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer PatientsPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 11, 2019ClinicalTrials.gov NCT03945721 · fetched Nov 12, 2026
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung CancerPHASE1 · TERMINATED · started Jun 6, 2019ClinicalTrials.gov NCT03891615 · fetched Nov 12, 2026
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 6, 2019ClinicalTrials.gov NCT03830918 · fetched Nov 12, 2026
A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian CancerPHASE2 · COMPLETED · started Nov 15, 2018ClinicalTrials.gov NCT03574779 · fetched Nov 12, 2026
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 11, 2018ClinicalTrials.gov NCT03602859 · fetched Nov 12, 2026
Niraparib in Patients With Pancreatic CancerPHASE2 · COMPLETED · started Aug 22, 2018ClinicalTrials.gov NCT03601923 · fetched Nov 12, 2026
A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyPHASE2 · COMPLETED · started Dec 12, 2017ClinicalTrials.gov NCT03326193 · fetched Nov 12, 2026
Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib CapsulePHASE1 · COMPLETED · started Dec 4, 2017ClinicalTrials.gov NCT03329001 · fetched Nov 12, 2026
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor MalignanciesPHASE1 · TERMINATED · started Oct 13, 2017ClinicalTrials.gov NCT03209401 · fetched Nov 12, 2026
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042PHASE1 · COMPLETED · started Oct 12, 2017ClinicalTrials.gov NCT03307785 · fetched Nov 12, 2026
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid TumorsPHASE1 · COMPLETED · started Aug 8, 2017ClinicalTrials.gov NCT03250832 · fetched Nov 12, 2026
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 11, 2016ClinicalTrials.gov NCT02655016 · fetched Nov 12, 2026
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)PHASE1 · ACTIVE_NOT_RECRUITING · started Jul 8, 2016ClinicalTrials.gov NCT02817633 · fetched Nov 12, 2026
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 7, 2016ClinicalTrials.gov NCT02715284 · fetched Nov 12, 2026